In Maryland, scientists have long known that breast cancer stem cells can survive chemotherapy, which is not good as those cells are usually in tumor centers and the ones you really want to get rid of because if they come back, the cancer is often fatal. Scientists found that proteins known as hypoxia-inducible factors (HIFs) are activated when exposed to chemotherapy and they then produce a protein called glutathione-S-transferase O1 (GSTO1) which turns on certain genes that help those nasty breast cancer stem cells survive. The gene expression analysis and experiments conducted in their lab showed that if they can block the HIFs, then the GSTO1 protein is never formed and the breast cancer stem cells couldn’t protect themselves against the chemotherapy, giving much hope for breast cancer patients.
Latest article
Data boom to data shroom: Mycelium could one day be data storage
In Ohio, scientists at Ohio State University have shown that mushroom mycelium can act as a form of data storage. In controlled lab experiments,...
Wooden compass points dementia patients back home
In the Netherlands, a startup has unveiled a device for dementia patients that is comprised of a single arrow that points to only one...
Snack to the future: Nutri3D wants to 3D print your next sweet treat
In Italy, researchers in the Nutri3D project have unveiled prototypes of nutrient-rich sweet snacks made from cultured plant cells, fruit byproducts, and 3D printing....